WPRIM Management System> DCMS> Journal of Breast Cancer> 2005> 8> 2

Volume: 8 Issue: 2

1. Combined Multimodality Treatment including Surgery. Page:69—73
2. Granulomatous mastitis. Page:64—68
3. The Clinicopathologic Characteristics of 38 Metaplastic Carcinomas of the Breast. Page:59—63
4. The Clinicopathologic Characteristics of 38 Metaplastic Carcinomas of the Breast. Page:59—63
5. Clinical Significance of DAX-1 Expression using Immunihistochemical Staining in Breast Cancer. Page:52—58
6. Clinical Significance of DAX-1 Expression using Immunihistochemical Staining in Breast Cancer. Page:52—58
7. Expression of estrogen receptor beta, estrogen receptor alpha and cyclooxygenase II in advanced breast cancer. Page:45—51
8. Expression of estrogen receptor beta, estrogen receptor alpha and cyclooxygenase II in advanced breast cancer. Page:45—51
9. FAS (Fatty acid synthase) expression in breast cancer. Page:40—44
10. FAS (Fatty acid synthase) expression in breast cancer. Page:40—44
11. Detection of micrometastasis in fixed paraffin-embedded Sentinel Lymph Nodes of Breast cancer using RT-PCR. Page:31—39
12. Detection of micrometastasis in fixed paraffin-embedded Sentinel Lymph Nodes of Breast cancer using RT-PCR. Page:31—39
13. Survival Analyses in Breast Cancer According to Over-expression and Amplification of HER2. Page:23—30
14. Survival Analyses in Breast Cancer According to Over-expression and Amplification of HER2. Page:23—30
15. Overexpression of the Bmi-1 Oncoprotein correlates with Axillary Lymph Node Metastases in Invasive Ductal Breast Cancer. Page:17—22
16. Overexpression of the Bmi-1 Oncoprotein correlates with Axillary Lymph Node Metastases in Invasive Ductal Breast Cancer. Page:17—22
17. Characterization of the Differentially Expressed Genes in Human Breast Cancer using Subtractive Hybridization. Page:10—16
18. Characterization of the Differentially Expressed Genes in Human Breast Cancer using Subtractive Hybridization. Page:10—16
19. Tamoxifen Resistance and Crosstalk of Signal Transduction in Breast Cancer. Page:4—9
20. Tamoxifen Resistance and Crosstalk of Signal Transduction in Breast Cancer. Page:4—9